Skip to content
PICO Portalanswers from OpenAlex

Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation

PaperCitations, authors & open-access status

Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation is a paper indexed in PICO Portal from OpenAlex.

How many citations does Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation have?

PICO Portalcitation count

Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation has 15 citations in the OpenAlex counts PICO Portal stores.

When was Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation published?

PICO Portalyear

Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation has 2019 year in the PICO Portal index.

What is the open-access status of Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation?

PICO Portaloa status

Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation has closed oa status in the PICO Portal index.

What is the DOI of Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation?

PICO Portaldoi

The DOI for Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation is on the source record.

What is the PMID of Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation?

PICO Portalpmid

The PMID for Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation is on the source record.

What is the OpenAlex record for Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation?

PICO Portalopenalex

The OpenAlex for Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial